cagrisema phase 3 results 2025 semaglutide cagrilintide obesity in Adults With or Without Diabetes – REDEFINE 1 & 2 • 💊 2.4 mg + 2.4 mg once weekly • 📉 –20.4% weight loss (non-diabetic) & –13.7% (T2D) Efficacy and safety of once-weekly

Novo Nordisk and Lilly are battling for coverage joined by some doctors and patient advocate groups, many funded by the drug companies

Influence of recent intake: Recent B12-rich meals or injections can temporarily raise serum levels, potentially masking a deficiency

What the research shows 15% Visceral fat reduction over 26 weeks (Tesamorelin, Phase III) 2 pathways GHRH + ghrelin, dual GH stimulation FDA-approved Tesamorelin component, for visceral-fat reduction 12 mo Trunk-fat & triglyceride benefits sustained over a year (study) Our medication is delivered from a state-licensed pharmacy in our network, right to your door when you need it

Amigorena, G

Enhanced GABAergic activity promotes calm without causing sedation

Place the pen against your skin at the injection site so that you can see the pens window